Introduction

The goal of the thematic programme "Health, Demographic Change and Well-being" is better health for all. Its main policy objectives are to improve health and well-being outcomes, to promote healthy and active ageing, to promote market growth, job creation, and the EU as a global leader in the health area. The challenges to this goal derive from the ageing of European population and lifestyle patterns, which, if not actively managed through a life-course approach, will increase the burden of chronic diseases on individuals, on existing health and care systems and on society.

Topics of the call

Research and Innovation Actions (RIA)

- SC1-PM-01-2016: Multi omics for personalised therapies addressing diseases of the immune system. The scope is to integrate and use high quality genome, epigenome, proteome, metabolome, microbiome data produced by large scale international initiatives with innovative imaging, functional, structural and lifestyle/environmental data, and combine these with disease-oriented functional analysis to contribute to the understanding of health and disease with the final objective of selecting relevant biomarkers for clinical validation that will lead to the development of new targeted therapies for diseases of the immune system. Budget: 12-15 Million euro. Deadline: 13 April 2016.

- SC1-PM-04–2016: Networking and optimising the use of population and patient cohorts at EU level. Proposals should aim at maximizing the exploitation of cohorts by bringing together national and/or European cohorts with common scientific interests (e.g. across diseases, children, mothers, elderly, birth, gender, etc.), and by taking advantage of new technologies and new type of data (e.g. geographical, genetic, eHealth records, etc.). Budget: 8-10 Million euro. Deadline: 13 April 2016.

- SC1-PM-06–2016: Vaccine development for malaria and/or neglected infectious diseases. Proposals will have to address bottlenecks in the discovery, preclinical and early clinical development of new vaccine candidates (antigens/adjuvants) for malaria and/or neglected infectious diseases. Budget: 3-5 Million for small-scale projects and 15-20 Million for large-scale projects. Deadline: 13 April 2016.

- SC1-PM-09–2016: New therapies for chronic diseases. Proposals should focus on clinical trial(s), supporting proof of concept of clinical safety and efficacy in humans [Phase 3 and phase 4 clinical trials are excluded] of novel therapies or the optimisation of available therapies for chronic non-communicable or chronic infectious diseases. Pre-clinical research should be completed before the start of the project. Budget: 4-6 Million euro. Deadline: 13 April 2016.

- SC1-PM-11–2016: Clinical research on regenerative medicine. Proposals should target regenerative medicine therapies which are ready for clinical (in-patient) research and should focus on one specific clinical phase of work. Any stage of clinical work may be proposed though later stages are preferred; clinical work should represent the core of the proposal. Budget: 4-6 Million euro. Deadline: 13 April 2016.

- SC1-PM-14–2016: EU-Japan cooperation on Novel ICT Robotics based solutions for active and healthy ageing at home or in care facilities. Joint research and innovation proposals for developing and demonstrating advanced ICT Robotics based solutions for extending active and healthy ageing. Proposals should build on advances in this domain, and should combine multi-disciplinary research involving behavioural, sociological, health and other relevant disciplines. Budget: 1-2 Million euro. Deadline: 12 April 2016.

- SC1-PM-18–2016: Big Data supporting Public Health policies. Focus on how to better acquire, manage, share, model, process and exploit the huge amount of data to develop integrated solutions that support public health authorities in healthcare system management, long-term policy making and increase the ability to provide actionable insights at the point of care. Budget: 3-5 Million euro. Deadline: 16 February 2016.

- SC1-PM-21-2016: Implementation research for scaling-up of evidence based innovations and good practice in Europe and low- and middle-income countries. Proposals should seek to replicate and scale up a comprehensive intervention in the field of health systems that is innovative and wellresearched, supported by sufficient documented evidence. This scaling up can take place within Europe as well as outside it, notably in low- and middle-income countries. Budget: 4-6 Million euro. Deadline: 13 April 2016.

Partnership criteria

At least three legal entities established in 3 EU Member States or associated countries.

Funding

The funding rate: 100% of total eligible costs.

More information at

http://ec.europa.eu/research/participants/portal/desktop/en/home.html